Karo Pharma AB (OSTO:KARO) Days Sales Outstanding : 0.00 (As of Jun. 2022)

View and export this data going back to 1998. Start your Free Trial

What is Karo Pharma AB Days Sales Outstanding?

Karo Pharma AB's average Accounts Receivable for the three months ended in Jun. 2022 was kr633 Mil. Karo Pharma AB's Revenue for the three months ended in Jun. 2022 was kr0 Mil.

The historical rank and industry rank for Karo Pharma AB's Days Sales Outstanding or its related term are showing as below:

OSTO:KARO's Days Sales Outstanding is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 72.3
* Ranked among companies with meaningful Days Sales Outstanding only.

Karo Pharma AB's Days Sales Outstanding declined from Mar. 2021 (80.62) to Jun. 2022 (0.00).

Karo Pharma AB Days Sales Outstanding Historical Data

The historical data trend for Karo Pharma AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karo Pharma AB Days Sales Outstanding Chart

Karo Pharma AB Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Sales Outstanding

Get a 7-Day Free Trial

67.40

51.98

74.70

68.24

75.42

Karo Pharma AB Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22
Days Sales Outstanding	Get a 7-Day Free Trial															80.62	80.64	86.94	82.40	-

Competitive Comparison of Karo Pharma AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Karo Pharma AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Karo Pharma AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Karo Pharma AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Karo Pharma AB's Days Sales Outstanding falls into.

Karo Pharma AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Karo Pharma AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2021 is calculated as

	Days Sales Outstanding (A: Dec. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2020 )	+	Accounts Receivable (A: Dec. 2021 ))	/	count )	/	Revenue (A: Dec. 2021 )	*	Days in Period
=	( (596.343	+	627.397)	/	2 )	/	2961.353	*	365
=	611.87					/	2961.353	*	365
=	75.42

Karo Pharma AB's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding (Q: Jun. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Jun. 2022 ))	/	count )	/	Revenue (A: Jun. 2022 )	*	Days in Period
=	( (627.397	+	639.1)	/	2 )	/	0	*	365 / 4
=	633.2485					/	0	*	365 / 4
=	N/A

Karo Pharma AB (OSTO:KARO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Karo Pharma AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Karo Pharma AB (OSTO:KARO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OSTO:KARO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22

Website

https://www.karopharma.com

Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.